2018 | | Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis | 서창희 |
2015 | | Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. | 김현아, 서창희, 정주양 |
2021 | | Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review | 김지원, 서창희, 정주양 |
2011 | | Replicated association of a regulatory polymorphism in the interferon γ gene with lupus susceptibility. | 서창희 |
2020 | | Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry | 김현아 |
2020 | | Retention rate and long-term safety of biosimilar CT-P13 in patients with ankylosing spondylitis: data from the Korean College of Rheumatology Biologics registry | 김현아 |
2023 | | Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study | 김지원, 김현아, 서창희, 정주양 |
2020 | | Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry | 김현아 |
2015 | | Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines. | 서창희 |
2005 | | Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. | 남동호, 박해심, 서창희, 조재현 |
2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
2022 | | Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis | 서창희 |
2015 | | Role of bone scan in the assessment of polymyositis/dermatomyositis. | 김현아, 서창희, 안영실, 정주양 |
2024 | | Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome | 김지원, 김현아, 서창희, 정주양, 한재호 |
2020 | | Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease | 김지원, 김현아, 서창희, 정주양 |
2023 | | Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study | 서창희 |
2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
2016 | | Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research | 서창희, 정주양 |
2021 | | Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review | 김지원, 김현아, 서창희, 정주양 |